Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?

David R. Fogelman, Holly Holmes, Khalil Mohammed, Matthew H.G. Katz, Carla M. Prado, Jessica Lieffers, Naveen Garg, Gauri R. Varadhachary, Rachna Shroff, Michael J. Overman, Christopher Garrett, Robert A. Wolff, Milind Javle

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?'. Together they form a unique fingerprint.

Medicine & Life Sciences